SCHEMBL3915213

SCHEMBL3915213

COCC1CCCN1S(=O)(=O)c1ccc(-c2ccc(CCN3CCCC3C)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 14/20 1.00
HRH3 Q9Y5N1 13/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14303490 1.00 KCNH2 (1.00) KCNH2HRH3
SCHEMBL14310561 1.00 KCNH2 (1.00) KCNH2HRH3
SCHEMBL3356256 0.88 KCNH2 (0.78) KCNH2HRH3
SCHEMBL14310577 0.88 KCNH2 (0.78) KCNH2HRH3
SCHEMBL14302700 0.88 HRH3 (0.78) KCNH2HRH3
SCHEMBL3326712 0.88 HRH3 (0.78) KCNH2HRH3
SCHEMBL14303871 0.86 KCNH2 (0.75) KCNH2HRH3
SCHEMBL3325617 0.86 KCNH2 (0.75) KCNH2HRH3
SCHEMBL3320691 0.84 KCNH2 (0.79) KCNH2HRH3
SCHEMBL14303494 0.84 KCNH2 (0.79) KCNH2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035372-A1 MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-03-18 EP claimed
WO-2008005338-A1 MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2008-01-10 WO claimed